AB143998
N-Dodecanoyl-NBD-ceramide trihexoside, Fluorescent C12:0-ceramide trihexoside analog
Be the first to review this product! Submit a review
|
(1 Publication)
MW 1146.33 g/mol, Purity >98%. Fluorescent C12:0-ceramide trihexoside analog (ab143966). For use in Fabry disease studies, ceramide trihexoside identification in samples and biological systems. Active in vitro.
1 Images
- Chemical Structure
Lab
Chemical Structure - N-Dodecanoyl-NBD-ceramide trihexoside, Fluorescent C12:0-ceramide trihexoside analog (AB143998)
2D chemical structure image of ab143998, N-Dodecanoyl-NBD-ceramide trihexoside, Fluorescent C12 : 0-ceramide trihexoside analog
Properties and storage information
Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C
Storage information
Store under desiccating conditions|The product can be stored for up to 12 months
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
Biomolecules 13: PubMed36671438
2022
Development of Lanzyme as the Potential Enzyme Replacement Therapy Drug for Fabry Disease.
Applications
Unspecified application
Species
Unspecified reactive species
Mulan Deng,Hongyu Zhou,Zhicheng Liang,Zhaoyang Li,Yanping Wang,Wanyi Guo,April Yuanyi Zhao,Fanghong Li,Yunping Mu,Allan Zijian Zhao
Product promise
We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com